FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 ORAL Beverly Hills Rejuvenation Center FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.